Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Socaci, G. Nini, C. Marica, E. Borgazi (Timisoara, Arad, Bucuresti, Constanta, Romania). Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents. Eur Respir J 2013; 42: Suppl. 57, 1607

Member's Comments

No comment yet.

Related content which might interest you: Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Evaluate the potential of IP-10 as biomarker for the MDR-TB treatment outcome Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 LATE-BREAKING ABSTRACT: The performance of flow cytometry in the diagnosis of latent tuberculosis infection in patients under treatment with anti-TNFa and other biological agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Use of interferon-gamma release assays in diagnosis of active TB infection - Experience of a rural UK hospital Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy Source: Eur Respir J 2014; 44: 1369-1372 Year: 2014 Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Time interval to conversion of interferon-? release assay after exposure to tuberculosis Source: Eur Respir J 2011; 37: 1447-1452 Year: 2011 Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Immunotherapy (as an adjuvant therapeutic tool) of tuberculosis - does it have a future? Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Diagnosis of tuberculosis: principles and practice of using Interferon-gamma release assays (IGRAs) Source: Breathe 2009; 5: 302-309 Year: 2009 Serial interferon-gamma release assay in children with tuberculosis infection Source: Annual Congress 2010 - Tuberculosis in children Year: 2010 The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant candidates Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Effect of prophylaxis on responses for ESAT-6/CFP-10 in whole blood IFN-g test Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis Year: 2005 Adherence to national guidelines for interferon gamma release assay in diagnosis of mycobacterium tuberculosis Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010